What should procurement teams evaluate first when entering the Atherectomy Devices Market as buyers?

Total cost per completed case, not list price. Embolic protection filters, wires, and extended procedure time frequently add 30–45% to the headline device cost [15]. Read More

How does operator training availability affect adoption timelines?

Proctored case requirements typically span 8–15 procedures before independent use. Centres without proctor access often delay launch by two or three quarters [9]. Read More

Do hospital group purchasing organizations constrain access to the Atherectomy Devices Market?

Yes, materially. GPO contracts frequently lock device categories for 24–36 months, and off-contract purchases require value-analysis committee override [14]. Read More

What integration challenges arise with existing cath lab equipment?

Console footprint and power requirements matter most in older labs. Some platforms also require specific guidewire compatibility, which fragments inventory management [26]. Read More

Which regulatory nuance most affects new entrants to the Atherectomy Devices Market?

Clinical evidence expectations differ sharply. European MDR now demands device-specific clinical data where equivalence claims previously sufficed, adding 12–18 months to launch timelines [8]. Read More

How are investors valuing pure-play suppliers in this space?

Revenue multiples compressed after 2023 consolidation. Buyers now price reimbursement durability and installed base over growth rate alone [16]. Read More

Where are the most credible emerging use cases?

Venous applications and dialysis access maintenance show early promise. Both involve fibrotic obstruction that responds to mechanical debulking [29]. Read More

Atherectomy Devices Market (2026 - 2035)

ID: MRFR/HC/5853-HCR 160 Pages Vikita Thakur Last Updated: September 15, 2026

Atherectomy Devices Market Research Report by Product Type (Directional Atherectomy Systems, Orbital Atherectomy Systems, and others), by Application (Cardiovascular, Neurovascular, Peripheral Vascular, and others), by End User Industry-Forecast Till 2035

Atherectomy Devices Market

Market Size

Forecast Period2026-2035

CAGR (2026-2035)7.0%

2025 Market SizeUSD 1.14 Billion

2035 Market SizeUSD 2.24 Billion

Key Players

Boston Scientific Corporation

Abbott Laboratories

Koninklijke Philips N.V.

Medtronic plc

Cardinal Health

Terumo Corporation

Trends

Peripheral Artery Disease Prevalence
Site-of-Service Migration
Imaging-Guided Vessel Preparation

Opportunities

Below-the-Knee Indication Expansion
Emerging-Market Entry Through Value Engineering
Procedural Data Monetization

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Report Takeaways |
1. 2.1 Takeaways by Product |
2. 2.2 Takeaways by Application |
3. 2.3 Takeaways by Geography
3 Global Market Size & Forecast (2021–2035) |
1. 3.1 Historical Market Size (2021–2025) |
2. 3.2 Current & Forecast Market Size (2026–2035) |
3. 3.3 Year-over-Year Growth Analysis
4 Market Drivers Analysis |
1. 4.1 Peripheral Artery Disease Prevalence |
2. 4.2 Site-of-Service Migration to Ambulatory Settings |
3. 4.3 Imaging-Guided Vessel Preparation |
4. 4.4 Asia-Pacific Capacity Expansion
5 Market Restraints Analysis |
1. 5.1 Reimbursement Scrutiny and Utilization Audits |
2. 5.2 Modality Competition from Intravascular Lithotripsy |
3. 5.3 Procedural Risk Profile
6 Market Opportunity Analysis |
1. 6.1 Below-the-Knee Indication Expansion |
2. 6.2 Emerging-Market Entry Through Value Engineering |
3. 6.3 Procedural Data Monetization |
4. 6.4 Combination Therapy Bundles |
5. 6.5 Ambulatory Channel Specialization |
6. 6.6 Industry Value Chain Analysis |
7. 6.7 Porter's Five Forces Analysis
7 Regional Analysis |
1. 7.1 North America | |
  1. 7.1.1 US | |
  2. 7.1.2 Canada | |
  3. 7.1.3 Mexico |
2. 7.2 Europe | |
  1. 7.2.1 Germany | |
  2. 7.2.2 UK | |
  3. 7.2.3 France | |
  4. 7.2.4 Italy | |
  5. 7.2.5 Spain | |
  6. 7.2.6 Nordic Countries | |
  7. 7.2.7 Russia | |
  8. 7.2.8 Rest of Europe |
3. 7.3 Asia-Pacific | |
  1. 7.3.1 China | |
  2. 7.3.2 India | |
  3. 7.3.3 Japan | |
  4. 7.3.4 South Korea | |
  5. 7.3.5 ASEAN | |
  6. 7.3.6 Rest of Asia-Pacific |
4. 7.4 South America | |
  1. 7.4.1 Brazil | |
  2. 7.4.2 Argentina | |
  3. 7.4.3 Rest of South America |
5. 7.5 Middle East & Africa | |
  1. 7.5.1 Saudi Arabia | |
  2. 7.5.2 UAE | |
  3. 7.5.3 South Africa | |
  4. 7.5.4 Egypt | |
  5. 7.5.5 Rest of Middle East & Africa
8 Future Outlook (2026–2035) |
1. 8.1 Algorithmic Procedure Guidance |
2. 8.2 Consumable-Led Platform Economics |
3. 8.3 Outcomes-Linked Purchasing |
4. 8.4 Supply Chain Regionalization
9 Segmentation Analysis |
1. 9.1 By Product | |
  1. 9.1.1 Rotational Systems | |
  2. 9.1.2 Orbital Systems | |
  3. 9.1.3 Directional Systems | |
  4. 9.1.4 Photo-Ablative (Laser) Systems |
2. 9.2 By Application | |
  1. 9.2.1 Peripheral Vascular Applications | |
  2. 9.2.2 Cardiovascular Applications | |
  3. 9.2.3 Neurovascular Applications |
3. 9.3 By End User | |
  1. 9.3.1 Hospitals and Surgical Centers | |
  2. 9.3.2 Ambulatory Care Centers | |
  3. 9.3.3 Others
10 Competitive Landscape |
1. 10.1 Market Concentration Analysis |
2. 10.2 Competitive Benchmarking Matrix |
3. 10.3 Company Profiles | |
  1. 10.3.1 Boston Scientific Corporation | |
  2. 10.3.2 Abbott Laboratories | |
  3. 10.3.3 Koninklijke Philips N.V. | |
  4. 10.3.4 Medtronic plc | |
  5. 10.3.5 Becton, Dickinson and Company | |
  6. 10.3.6 Cardinal Health (Cordis) | |
  7. 10.3.7 Terumo Corporation | |
  8. 10.3.8 AngioDynamics, Inc. | |
  9. 10.3.9 Avinger, Inc. | |
  10. 10.3.10 Rex Medical, L.P. | |
  11. 10.3.11 Straub Medical AG
11 Recent News & Developments
12 Report Scope & Methodology |
1. 12.1 Study Period & Base Year |
2. 12.2 Data Sources & Citations |
3. 12.3 Abbreviations
13 Detailed Sources and Citations
14 Frequently Asked Questions
15 LIST OF TABLES
16 LIST OF FIGURES

Certified Researchers

Enquiry

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Product	Directional Atherectomy Systems; Orbital Atherectomy Systems; Photo-Ablative (Laser) Atherectomy Systems; Rotational Atherectomy Systems	Rotational Atherectomy Systems	Orbital Atherectomy Systems
By Application	Peripheral Vascular Applications; Cardiovascular Applications; Neurovascular Applications	Peripheral Vascular Applications	Neurovascular Applications
By End User	Hospitals and Surgical Centers; Ambulatory Care Centers; Others	Hospitals and Surgical Centers	Ambulatory Care Centers
By Geography	North America; Europe; Asia-Pacific; South America; Middle East & Africa	North America	Asia-Pacific

Market Segmentation Overview

By Product

Sub-Segment	Key Trend
Rotational Systems	Entrenched in coronary practice; incremental burr and shaft refinements rather than platform change
Orbital Systems	Fastest expansion; bidirectional sanding favored for eccentric peripheral calcium
Directional Systems	Tissue-capture advantage sustains femoropopliteal use despite higher unit cost
Photo-Ablative (Laser) Systems	Concentrated in in-stent restenosis and thrombotic lesion management

Product choice is converging on lesion morphology rather than institutional preference, which rewards suppliers offering more than one modality under a single contract.

By Application

Sub-Segment	Key Trend
Peripheral Vascular Applications	Largest revenue pool; limb salvage economics justify device escalation
Cardiovascular Applications	Steady growth constrained by lithotripsy substitution in calcified anatomy
Neurovascular Applications	Smallest base; early clinical exploration in carotid and intracranial disease

Peripheral work will keep carrying the category through 2035, though neurovascular represents the largest proportional upside if clearance pathways open.

By End User

Sub-Segment	Key Trend
Hospitals and Surgical Centers	Retains complex and high-risk cases requiring surgical backup
Ambulatory Care Centers	Fastest-growing channel; price-sensitive, fast-cycle purchasing behavior
Others	Specialty vascular clinics and clinical research sites

The ambulatory shift is the single most consequential channel change of the decade, and suppliers still organized around hospital committee selling risk losing share to more nimble competitors.

By Geography

Sub-Segment	Key Trend
North America	Reimbursement-driven dominance tempered by audit exposure
Europe	Regulatory compliance costs reshaping the supplier field
Asia-Pacific	Capacity buildout and domestic manufacturing driving fastest growth
South America	Private insurance penetration determines premium device access
Middle East & Africa	Diabetes burden creates clinical need ahead of operator supply

Geographic strategy increasingly requires distinct commercial models per region — a single global playbook no longer performs across such divergent payment systems.

Certified Researchers

Enquiry

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”